Algae Biofuel: Why Not Now?

Publisher: Emerging Tech Insights, Inc.
Published: September 2011
Pages: 87

Price:

A Strategic Technology Assessment

Algae biofuel is either just around the corner or off in the distant future. Which? We used a patented technology mapping process from Emerging Tech Insights, Inc. to answer the question and to Get Beyond the Hype® in algae biofuels.

Based on our analysis, algae biofuel or biodiesel does appear to be poised to disrupt the liquid fuel business. Commercial sales are quietly beginning in “specialty” markets. Our analysis of the technology landscape shows that there are few technological barriers. For most process steps, well characterized methods can be drawn from a parallel industry. Only large-scale culture systems need further “standardization” to enable a large-scale algae biofuel industry to break out, and even here a limited number of well-defined options already exist.

Our analysis clearly shows the adjacent markets that can serve as outlets for algae biofuel “waste” products, reducing scrap costs. Adjacent markets can also serve to finance biofuel market development.

When an algae biofuel industry breaks out, we believe that existing smaller players will begin to consolidate and our cutting-edge models suggest combinations of companies where intellectual property enhancements might exist.

When a large scale algae biofuel industry does break out, we also believe that winners will include the equipment and chemical suppliers for “standardized” ponds and bioreactors, new aqua culture farmers, suppliers of extraction equipment and chemicals, certain real estate holders and the investors and managers who made it all happen.

If you are considering investment in the algae biofuel area, this report will help you decide where to invest your R&D effort or where an acquisition or partnership might be the best approach. It will give you an inside look at existing competitors and where they are investing today and what they may have already abandoned.

You don’t need to take our word for it. With this report, you also gain access to the unique technology landscape model from which the conclusions were drawn.

Report Table of Contents (TOC) [Click Here to Download PDF File]

For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News

Optimising NGS workflows – an interview with Dr Mike Quail, Team Leader at the Sanger Institute
In this week's blog entry - http://bit.ly/15HpwvN - Dr Quail gives us some insight into the current advances being made in NGS, as well as some of the challenges still facing the optimisation of NGS pipelines. Dr Quail will be speaking at ELA 2013 about the new NGS applications being developed at the Sanger Institute, as well as some of improvements his team are making to sequencing protocols.

New ELA Blog
In the run up to European Lab Automation 2013, we’ll be sharing some interesting news and insights around the event on our new blog - http://tinyurl.com/aafeu9f . We’d be delighted if you’d like to comment on some of our blog posts, adding your own thoughts and generally become a valued part of the conversation!

The future of HCA using primary cells and 3D culture
This week’s ELA blog - http://bit.ly/15HpwvN -discusses the impact of process optimisation on cell based assays, with particular reference to High Content Analysis (HCA). To give us the inside scoop, we chatted with Dr Anthony Davies, Director of the High Content Research Facility at the Irish National Center for High Content Screening and Analysis (INCHSA) at Trinity College, Dublin, about the impact automation has had on the workflow at INCHSA. Dr Davies will also be sharing his expertise at E

'Illuminating Cellular Pathways through Combining High Content Assays with the BDA Method'
Keynote talk to be delivered by Dr Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Center 'Illuminating Cellular Pathways through Combining High Content Assays with the BDA Method: Too Much Hay and Very Few Needles in Random RNAi Screening Stacks' at the DDA: High-content Screening & Cell Based Assays conference track at ELA. For the full agenda, please view: http://bit.ly/YSUu0P

5 Reasons Not to Miss ELA 2013
We understand that staying up-to-date on the latest technologies boosting efficiency and effectiveness in the lab can be challenging. That’s exactly why we created ELA. Our latest blog entry - http://bit.ly/15HpwvN - highlights five key reasons not to miss this year’s event, all based on feedback we’ve received from past attendees.

Post Event Lab Tour
On November 14th there will be a post event lab tour, free for Lab-on-a-Chip Asia conference attendees. This will include visits to Singapore Institute of Manufacturing Technology, Nanyang Technological University, and National University of Singapore.